US Physical Therapy, Inc. (USPH) Misses Q2 EPS by 3c; Boosts FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts USPH Hot Sheet
Price: $79.35 +0.90%
Revenue Growth %: +8.5%
Financial Fact:
Provision for doubtful accounts: 917K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +8.5%
Financial Fact:
Provision for doubtful accounts: 917K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
US Physical Therapy, Inc. (NASDAQ: USPH) reported Q2 EPS of $0.41, $0.03 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $59.91 million versus the consensus estimate of $63.8 million.
The average net patient revenue per visit for the recent quarter was $105.65 as compared to $104.77 in the comparable 2011 period.
US Physical Therapy, Inc. sees FY2012 EPS of $1.49-$1.55, versus the consensus of $1.56.
For earnings history and earnings-related data on US Physical Therapy, Inc. (USPH) click here.
The average net patient revenue per visit for the recent quarter was $105.65 as compared to $104.77 in the comparable 2011 period.
US Physical Therapy, Inc. sees FY2012 EPS of $1.49-$1.55, versus the consensus of $1.56.
For earnings history and earnings-related data on US Physical Therapy, Inc. (USPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
- JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
